Emma Boehm

305 Grattan St
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Whole genome and exome sequencing of pancreatic neuroendocrine tumour to investigate PRRT response.

Whole genome and exome sequencing of pancreatic neuroendocrine tumour to investigate PRRT response.

Journal: Endocrine-related cancer

Published: April 20, 2026

Safety and efficacy of re-treatment with [177Lu]Lu-DOTA-Octreotate radionuclide therapy in progressive gastro-entero-pancreatic neuroendocrine tumours - a single centre experience.

Safety and efficacy of re-treatment with [177Lu]Lu-DOTA-Octreotate radionuclide therapy in progressive gastro-entero-pancreatic neuroendocrine tumours - a single centre experience.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 10, 2025

Unmasking insulinoma following commencement of somatostatin analogues in malignant neuroendocrine tumours.

Unmasking insulinoma following commencement of somatostatin analogues in malignant neuroendocrine tumours.

Journal: Endocrine oncology (Bristol, England)

Published: January 12, 2025

Approach to the Management of Gastrointestinal Manifestations in Patients With Phaeochromocytoma and Paraganglioma.

Approach to the Management of Gastrointestinal Manifestations in Patients With Phaeochromocytoma and Paraganglioma.

Journal: Clinical endocrinology

Published: December 15, 2024

Recent progress in molecular classification of phaeochromocytoma and paraganglioma.

Recent progress in molecular classification of phaeochromocytoma and paraganglioma.

Journal: Best practice & research. Clinical endocrinology & metabolism

Published: September 13, 2024

Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles.

Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles.

Journal: Research square

Published: July 09, 2024

Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles.

Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles.

Journal: Nature communications

Published: June 15, 2024

Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms.

Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms.

Journal: Endocrine oncology (Bristol, England)

Published: April 16, 2024

Metanephrine mirage: distinguishing the phaeocopies, a case report and literature review.

Metanephrine mirage: distinguishing the phaeocopies, a case report and literature review.

Journal: Clinical diabetes and endocrinology

Published: April 05, 2024

Systemic and iatrogenic factors contribute to the development of severe hypernatraemia in vulnerable inpatients.

Systemic and iatrogenic factors contribute to the development of severe hypernatraemia in vulnerable inpatients.

Journal: Clinical endocrinology

Published: May 10, 2023

Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN).

Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN).

Journal: Current oncology reports

Published: January 05, 2023

Empiric radioiodine for hyperthyroidism: Outcomes, prescribing patterns, and its place in the modern era of theranostics.

Empiric radioiodine for hyperthyroidism: Outcomes, prescribing patterns, and its place in the modern era of theranostics.

Journal: Clinical endocrinology

Published: January 24, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026